Clinical trial
A Multi-center, Randomized, Double-blind Controlled Study on the Sequential Treatment of Psoriasis With Traditional Chinese and Western Medicine
NCT05042635 is registered in ClinicalTrials.gov with Shanghai Yueyang Integrated Medicine Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Double-blind Controlled Study on the Sequential Treatment of Psoriasis With Traditional Chinese and Western Medicine
- Lead sponsor
- Shanghai Yueyang Integrated Medicine Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 1, 2021
- Completion date
- September 30, 2024
- Enrollment
- 90 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
plaque psoriasis